Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
OXYGENTAPH.BOthis companyOxygenta Pharmaceutical Ltd.	₹50.00	-10.19×	-4.19×	1.58×	-18.64×	-1043.4%	0.8%	-15.7%	-15.6%	41.2%	-20.6%	-25.3%	-2.57×	-6.99×	-3.7×	0.6×	0.0%	3	1.14	1	D+
AAREYDRUGS.NSAarey Drugs & Pharmaceuticals Limited	₹109.04	36.51×	0.96×	0.31×	14.58×	-99.9%	3.0%	0.9%	0.8%	2.6%	1.6%	-16.1%	0.33×	3.66×	0.86×	1.81×	0.0%	6	—	2	C
ANUHPHR.NSAnuh Pharma Limited	₹82.78	16.37×	1.91×	0.87×	10.04×	12.6%	17.4%	6.5%	5.3%	11.7%	10.8%	-1.6%	0×	-0.12×	106.58×	2.22×	2.2%	—	—	2	C
HIKAL.NSHikal Limited	₹225.40	-37.14×	1.51×	1.06×	16.85×	-107.8%	30.2%	3.3%	-2.8%	-4.1%	1.8%	4.9%	0.57×	4.57×	0.91×	1.3×	0.7%	3	—	1	C-
INFINIUM.NSInfinium Pharmachem Ltd.	₹269.95	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
KIMIABL.BOKimia Biosciences Ltd.	₹30.08	14.36×	6.02×	0.93×	9.9×	58.3%	24.6%	9.0%	6.5%	41.9%	16.9%	-1.8%	1.96×	2.42×	2.95×	1.04×	0.0%	3	—	2	B-
Peer median	—	15.37×	1.71×	0.9×	12.31×	-43.7%	21.0%	4.9%	3.1%	7.1%	6.3%	-1.7%	0.45×	3.04×	1.93×	1.56×	0.3%	3	—	2	—